Search

Your search keyword '"Umberto Basso"' showing total 357 results
Start Over Author "Umberto Basso"
357 results on '"Umberto Basso"'

354. Older age limits the use of adjuvant chemotherapy according to all negative risk factors in early breast cancer patients

Author

Antonella Brunello, Franco Lumachi, L. M. Pasetto, C. Pogliani, Umberto Basso, S. Monfardini, Alicia Tosoni, and Alba A. Brandes

Subjects
Oncology, endocrine system, Cancer Research, medicine.medical_specialty, breast diseases, business.industry, Adjuvant chemotherapy, menopause, mastectomy, Breast cancer, menopause, breast diseases, elderly, adjuvant chemotherapy, breast conserving surgery, mastectomy, medicine.disease, elderly, breast conserving surgery, adjuvant chemotherapy, Breast cancer, Internal medicine, medicine, business, Early breast cancer
Abstract

8159 Background: Adjuvant chemotherapy of elderly women is currently perceived as one of the priorities in breast cancer (BC) research and prospective trials are still lacking. We performed a retro...

355. MULTIDISCIPLINARY MANAGEMENT OF PROSTATE CANCER PATIENTS: THE PerSTEP DATA

Author

Magnani, Tiziana, Labianca, Roberto, Baier, Susanne, Baldazzi, Valentina, Barni, Sandro, Barone, Carlo, Bassi, Pierfrancesco, Basso, Umberto, Beatrici, Valerio, Bellardita, Lara, Bertolotto, Franco, Bombardieri, Emilio, Roberto Bortolus, Bracarda, Sergio, Bunkheila, Feisal, Cagna, Emanuela, Cazzaniga, Luigi Franco, Ceresoli, Giovanni Luigi, Corti, Luigi, D Agostino, Giuseppe A., Da Pozzo, Luigi, Angelis, Michele, Di Grazia, Alfio, Facchini, Gaetano, Ferrau, Francesco, Fragala, Eugenia, Fratino, Lucia, Frezza, Giovanni, Gabrielloni, Giuliana, Garbeglio, Antonio, Garibaldi, Elisabetta, Giordano, Monica, Graiff, Claudio, Guttilla, Andrea, Hurle, Rodolfo, Kaelli, Maurizio, Lapini, Alberto, Lastrucci, Luciana, Livi, Lorenzo, Lukas, Peter, Mantini, Giovanna, Marafioti, Luigi, Martorana, Giuseppe, Mattioli, Rodolfo, Micheli, Emanuele, Morgia, Giuseppe, Muto, Giovanni, Muto, Paolo, Orsatti, Marco, Ortega, Cinzia, Palazzo, Salvatore, Perdona, Sisto, Pinto, Francesco, Prati, Veronica, Procopio, Giuseppe, Pycha, Armin, Repetto, Lazzaro, Sarti, Enrico, Scarzello, Giovanni, Schiavina, Riccardo, Schinzari, Giovanni, Stagni, Silvia, Valentini, Vincenzo, Valdagni, Riccardo, Vavassori, Ivano, Vavassori, Vittorio, Ventura, Francesco, Villa, Sergio, Vitali, Elisabetta, Zagonel, Vittorina, Zani, Tania, Zattoni, Filiberto, Zucali, Paolo Andrea, Gabriele, Pietro, Conti, Giario, SIU, Magnani, T., Labianca, R., Baier, S., Baldazzi, V., Barni, S., Barone, C., Bassi, P., Basso, U., Beatrici, V., Bellardita, L., Bertolotto, F., Bombardieri, E., Bortolus, R., Bracarda, S., Bunkheila, F., Cagna, E., Cazzaniga, L., Ceresoli, G., Corti, L., D'Agostino, G., Da Pozzo, L., De Angelis, M., Di Grazia, A., Facchini, G., Ferraù, F., Fragalà, E., Fratino, L., Frezza, G., Gabrielloni, G., Garbeglio, A., Garibaldi, E., Giordano, M., Graiff, C., Guttilla, A., Hurle, R., Kaelli, M., Lapini, A., Lastrucci, L., Livi, L., Lukas, P., Mantini, G., Marafioti, L., Martorana, G., Mattioli, R., Micheli, E., Morgia, G., Muto, G., Muto, P., Orsatti, M., Ortega, C., Palazzo, S., Perdonà, S., Pinto, F., Prati, V., Procopio, G., Pycha, A., Repetto, L., Sarti, E., Scarzello, G., Schiavina, R., Schinzari, G., Stagni, S., Valentini, V., Valdagni, R., Vavassori, I., Vavassori, V., Ventura, F., Villa, S., Vitali, E., Zagonel, V., Zani, T., Zattoni, F., Zucali, P., Gabriele, P., Conti, G., Tiziana Magnani, Roberto Labianca, Susanne Baier, Valentina Baldazzi, Sandro Barni, Carlo Barone, Pierfrancesco Bassi, Umberto Basso, Valerio Beatrici, Lara Bellardita, Franco Bertolotto, Emilio Bombardieri, Roberto Bortolu, Sergio Bracarda, Feisal Bunkheila, Emanuela Cagna, Luigi Franco Cazzaniga, Giovanni Luigi Ceresoli, Luigi Corti, Giuseppe A D’agostino, Luigi Da Pozzo, Michele De Angeli, Alfio Di Grazia, Gaetano Facchini, Francesco Ferraù, Eugenia Fragalà, Lucia Fratino, Giovanni Frezza, Giuliana Gabrielloni, Antonio Garbeglio, Elisabetta Garibaldi, Monica Giordano, Claudio Graiff, Andrea Guttilla, Rodolfo Hurle, Maurizio K lli, Alberto Lapini, Luciana Lastrucci, Lorenzo Livi, Peter Luka, Giovanna Mantini, Luigi Marafioti, Giuseppe Martorana, Rodolfo Mattioli, Emanuele Micheli, Giuseppe Morgia, Giovanni Muto, Paolo Muto, Marco Orsatti, Cinzia Ortega, Salvatore Palazzo, Sisto Perdonà, Francesco Pinto, Veronica Prati, Giuseppe Procopio, Armin Pycha, Lazzaro Repetto, Enrico Sarti, Giovanni Scarzello, Riccardo Schiavina, Giovanni Schinzari, Silvia Stagni, Vincenzo Valentini, Riccardo Valdagni, Ivano Vavassori, Vittorio Vavassori, Francesco Ventura, Sergio Villa, Elisabetta Vitali, Vittorina Zagonel, Tania Zani, Filiberto Zattoni, Paolo Andrea Zucali, Pietro Gabriele, and Giario Conti

Subjects
MULTIDISCIPLINARY MANAGEMENT OF PROSTATE CANCER PATIENTS: THE PERSTEP DATA

356. Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.

Author

Michele D, Umberto B, Gaetano R, Francesco P, Davide B, Francesca C, Zagone V, and Marco M

Abstract

The role of percutaneous tumour biopsies had gain importance in the management of renal cell carcinoma to provide diagnostic specimen for the patients with metastatic disease that could benefit a systemic treatment. Among the possible complications of this procedure, however, there is the risk of tumoral cells seeding along the biopsy's tract; this complication, albeit being reported as anecdotal, could have devastating effects. Here we report a case of a young male who developed subcutaneous chest metastasis of renal cell carcinoma after a biopsy of a lung nodule. We subsequently reviewed other cases reported in literature., Competing Interests: Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2021.)

Published
2021
Full Text
View/download PDF

357. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

Author

Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, and Gillessen S

Subjects
Adult, Aged, Combined Modality Therapy, Humans, Male, Middle Aged, Neoplasm Staging, Orchiectomy, Recurrence, Seminoma mortality, Testicular Neoplasms mortality, Treatment Outcome, Carboplatin therapeutic use, Chemotherapy, Adjuvant, Seminoma therapy, Testicular Neoplasms therapy
Abstract

Purpose Adjuvant carboplatin is one of three management strategies that may follow inguinal orchiectomy in clinical stage I seminoma. However, little is known about the outcome of patients who experience a relapse after such treatment. Patients and Methods Data from 185 patients who relapsed after adjuvant carboplatin between January 1987 and August 2013 at 31 centers/groups from 20 countries were collected and retrospectively analyzed. Primary outcomes were disease-free survival and overall survival. Secondary outcomes were time to, stage at, and treatment of relapse as well as rate of subsequent relapses. Results With a median follow-up of 53 months (95% CI, 48 to 60 months) the 5-year disease-free survival was 82% (95% CI, 77% to 89%), and the 5-year overall survival was 98% (95% CI, 95% to 100%). The median time from orchiectomy to relapse was 19 months (95% CI, 17 to 23 months); 15% (95% CI, 10% to 21%) of relapses occurred > 3 years after treatment. The majority of relapses were detected by computed tomography scan during routine follow-up, 98% in the International Germ Cell Cancer Collaborative Group good prognosis group. Chemotherapy was administered to 92% of patients, mostly as standard first-line treatment corresponding to stage; 8% of patients had additional local treatments. Only 28 patients experienced a second relapse. At last follow-up, 174 (94%) of 185 patients were alive without disease, and four patients with disease. Seven patients died, three of whom due to progressive disease. Conclusion Within the limitations of a retrospective analysis, the results suggest that the majority of patients who experience a relapse after adjuvant carboplatin for clinical stage I seminoma can be successfully treated with a cisplatin-based chemotherapy regimen adequate for stage. Because 15% of the relapses occurred > 3 years after adjuvant treatment, a minimum of 5 years follow-up is recommended.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results